Kabir Nath

Steve Moore, an economist and Trump advisor, shares insights on Fed policy and fiscal responsibility, critiquing pandemic stimulus. Zach Wasserman, CFO of Huntington Bancshares, discusses bank growth, lending strategies, and the impacts of AI. Energy reporter Josh Saul reveals how NextEra is adapting to data center demands, while Kabir Nath of Compass Pathways highlights the promise of psilocybin therapies for mental health. Chris Anthony discusses Aptera's innovative solar-electric vehicle, and Chris Rauser offers tips on estate organization and gift-giving.

Kabir Nath, CEO of Compass Pathways, leads the charge in developing COMP360 psilocybin therapy for treatment-resistant depression. He discusses the resurgence of the psychedelics market and the promising results of their Phase 3 trials. Kabir shares insights on the regulatory landscape, detailing their engagement with the FDA and next steps toward market launch. He also addresses safety measures, potential applications beyond depression, and the company’s commitment to equitable access for patients. With a target of 3 million patients, the future of mental health treatment looks brighter than ever!

Laura Martin, a senior analyst at Needham & Company, dives into the dynamics of the Mag7 stocks and market trends. Pascal Soriot, CEO of AstraZeneca, discusses the company's ambitious $50 billion investment in U.S. production and the competition with China. Kabir Nath, of Compass Pathways, shares insights into developing psilocybin for depression treatment. Meanwhile, Hannah Elliott explores the quirky Tesla Diner experience and its connection to key fobs. Ted Alcorn reveals Burning Man's financial struggles and cultural essence, highlighting the festival's complex financial landscape.